Compare American Well Corp (AMWL) vs Tesla, Inc. (TSLA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Well Corp vs Tesla, Inc. — how do they compare? American Well Corp trades at $12.73 (market cap $220.94M), while Tesla, Inc. trades at $325.86 (market cap $1.31T). The key difference: Tesla, Inc. is far larger — about 5929.2× American Well Corp's market cap, and American Well Corp is trading nearer its 52-week high, Tesla, Inc. nearer its low. Which is the better fit depends on your goals.
| AMWL | TSLA | |
|---|---|---|
Market Cap | $220.94M | $1.31T |
Sector | Health | Consumer Cyclical |
52-Week High | $13.58 | $489.88 |
52-Week Low | $3.78 | $298.16 |
Enterprise Value | $27.98M | $1.29T |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMWL trades at $12.93, down 4.79% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported Q2 2026 revenue of $52 million, beating estimates, and continues to narrow losses, targeting cash-flow breakeven by Q4 2026. Recent news includes a key executive joining Amazon's healthcare unit, highlighting strategic relevance.
Outlook hinges on achieving profitability targets amid declining revenues. Opportunities include operational efficiency gains and high-profile partnerships, but risks persist from sustained net losses and competitive pressures. Analyst consensus is cautious with 67% hold ratings.
Tesla (TSLA) trades at $326.58, down 1.3% over the past 24 hours, with a bearish technical signal driven by moving averages. The stock shows elevated valuation ratios, including a P/E of 308.16 and P/S of 11.36, while recent earnings performance was mixed with a Q2 2026 miss. Cash flow trends indicate heavy capital expenditure, and revenue growth has slowed, with net income margin at 3.67% for 2025. Recent news highlights regulatory approval for driver-assistance software in Europe and discussions on Tesla's strategic pivot toward AI and robotics.
Tesla faces near-term headwinds from valuation concerns and competitive pressures, but long-term growth potential hinges on autonomous driving technology and energy segment expansion. Key risks include execution challenges in new business lines and macroeconomic sensitivity. Analyst consensus is mixed with a $393.87 price target, suggesting cautious optimism amid high volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Well Corp
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.
Read more on AMWL →About Tesla, Inc.
Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.
Read more on TSLA →
